Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
Clinical trial NCT03007030 · RECRUITING
Trial details
- NCT number
- NCT03007030
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-05
- Primary completion
- 2027-05-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.